不同浓度异丙酚作为**麻醉剂对瞳孔直径的影响:随机试验

2020-08-12 翻译:任文鑫 编辑:冯玉蓉 审校:曹莹 罂粟花

我们的目的是探讨异丙酚的预测效应点浓度(CET)在1-3µg/mL范围内与瞳孔直径之间的潜在关系。

背景:全身麻醉下的瞳孔测量监测是基于瞳孔直径变化可反映所提供的镇痛是否满足伤害性手术刺激疼痛强度这一假设。要准确解释瞳孔测量学数据,就必须清楚地确定在每个特定催眠状态下,未受刺激的瞳孔直径的预期基线是多少。阿片类药物以剂量依赖的方式减小瞳孔直径。相比之下,催眠药对瞳孔直径的影响尚未可知。我们的目的是探讨异丙酚的预测效应点浓度(CET)在1-3µg/mL范围内与瞳孔直径之间的潜在关系。

 

方法:患者随机接受异丙酚靶控输注,预计CET为1、2或3µg/mL(分别为P1、P2和P3组)。在随机分组的CET中,稳态输注异丙酚10分钟后进行瞳孔直径测量。研究过程中未进行任何刺激。连续记录心率和脑电双频指数(BIS)。

 

结果:共纳入40例全麻患者:P1组有13例,P2组有14例,P3组有13例。P1组平均瞳孔直径为5.7 mm(1 Mm),P2组平均瞳孔直径为4.8 mm(1.3 mm),P3组平均瞳孔直径为3.3 mm(0.8 mm)。异丙酚对瞳孔直径有剂量依赖性影响(线性回归R2=0.45,P<0.001)。瞳孔直径与BIS值呈正相关(Spearman r=0.75[95%CI 0.5 4,−0.87],P<0.0 0 1)。

 

结论:在1~3µg/mL的预测CET范围内,异丙酚对瞳孔直径有剂量依赖性影响。在此浓度范围内,BIS与瞳孔直径呈正相关。异丙酚对瞳孔直径皮质下的影响与其对大脑皮层的影响有关。评估瞳孔直径作为伤害性-抗伤害性平衡指标的研究应该在具有标准深度催眠的患者中进行。

 

文献来源:Sabourdin N, Meniolle F, Chemam S, et al. Effect of Different Concentrations of Propofol Used as a Sole Anesthetic on Pupillary Diameter: A Randomized Trial.[J].Anesth Analg 2020,131:510-517.

 

Effect of Different Concentrations of Propofol Used as a Sole Anesthetic on Pupillary Diameter: A Randomized Trial

Abstract

BACKGROUND: Pupillometry monitoring under general anesthesia is based on the assumption that pupillary diameter variations reflect the adequacy of the provided analgesia to the intensity of the nociceptive surgical stimulus. The accurate interpretation of pupillometric data requires establishing clearly what the expected baseline unstimulated pupillary diameter at each specific level of hypnosis is. Opioids decrease pupillary diameter in a dose-dependent fashion. In contrast, the effects of hypnotic drugs on pupillary diameter are not well known. Our aim was to describe the potential relationship between propofol predicted effect-site concentrations (Cets) ranging from 1 to 3 µg/mL and pupillary diameter.

 

METHODS: Patients were randomized to receive propofol by target-controlled infusion at a predicted Cet of 1, 2, or 3 µg/mL (groups P1, P2, and P3, respectively). Pupillary diameter measurements were performed after 10 minutes of steady-state propofol infusion at the randomized Cet. No stimulation was performed during the study. Heart rate and bispectral index (BIS) were continuously recorded.

 

RESULTS: Forty patients were included: (13, 14, and 13 in groups P1, P2, and P3, respectively). Mean pupillary diameter was 5.7 mm (1 mm) in group P1, 4.8 mm (1.3 mm) in group P2, and 3.3 mm (0.8 mm) in group P3. Propofol had a dose-dependent effect on pupillary diameter (linear regression R2 = 0.45, P < .001). Pupillary diameter was positively correlated with the BIS (Spearman r = 0.75 [95% confidence interval (CI), 0.54 to −0.87] P < .001).

 

CONCLUSIONS: From 1 to 3 µg/mL of predicted Cet, propofol has a dose-dependent effect on pupillary diameter. Within this concentrations range, there is a positive correlation between BIS and pupillary diameter. The subcortical effect of propofol on pupillary diameter is correlated to its effect on the cortex. Studies assessing pupillary diameter as a marker of the nociception–antinociception balance should be performed in patients with a standardized depth of hypnosis.

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1393228, encodeId=c3271393228ef, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468850, encodeId=a0ba1468850ed, content=<a href='/topic/show?id=5e0b49e1106' target=_blank style='color:#2F92EE;'>#异丙酚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49711, encryptionId=5e0b49e1106, topicName=异丙酚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18a56942427, createdName=lq0303, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512165, encodeId=b5cc151216508, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544657, encodeId=b80e154465e1b, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038947, encodeId=19a3103894e60, content=高质量研究,读起来真爽,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Wed Aug 12 14:17:44 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-14 小几洁
  2. [GetPortalCommentsPageByObjectIdResponse(id=1393228, encodeId=c3271393228ef, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468850, encodeId=a0ba1468850ed, content=<a href='/topic/show?id=5e0b49e1106' target=_blank style='color:#2F92EE;'>#异丙酚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49711, encryptionId=5e0b49e1106, topicName=异丙酚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18a56942427, createdName=lq0303, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512165, encodeId=b5cc151216508, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544657, encodeId=b80e154465e1b, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038947, encodeId=19a3103894e60, content=高质量研究,读起来真爽,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Wed Aug 12 14:17:44 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-14 lq0303
  3. [GetPortalCommentsPageByObjectIdResponse(id=1393228, encodeId=c3271393228ef, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468850, encodeId=a0ba1468850ed, content=<a href='/topic/show?id=5e0b49e1106' target=_blank style='color:#2F92EE;'>#异丙酚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49711, encryptionId=5e0b49e1106, topicName=异丙酚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18a56942427, createdName=lq0303, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512165, encodeId=b5cc151216508, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544657, encodeId=b80e154465e1b, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038947, encodeId=19a3103894e60, content=高质量研究,读起来真爽,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Wed Aug 12 14:17:44 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1393228, encodeId=c3271393228ef, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468850, encodeId=a0ba1468850ed, content=<a href='/topic/show?id=5e0b49e1106' target=_blank style='color:#2F92EE;'>#异丙酚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49711, encryptionId=5e0b49e1106, topicName=异丙酚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18a56942427, createdName=lq0303, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512165, encodeId=b5cc151216508, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544657, encodeId=b80e154465e1b, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038947, encodeId=19a3103894e60, content=高质量研究,读起来真爽,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Wed Aug 12 14:17:44 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1393228, encodeId=c3271393228ef, content=<a href='/topic/show?id=34aae3121a7' target=_blank style='color:#2F92EE;'>#瞳孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73121, encryptionId=34aae3121a7, topicName=瞳孔)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468850, encodeId=a0ba1468850ed, content=<a href='/topic/show?id=5e0b49e1106' target=_blank style='color:#2F92EE;'>#异丙酚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49711, encryptionId=5e0b49e1106, topicName=异丙酚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18a56942427, createdName=lq0303, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512165, encodeId=b5cc151216508, content=<a href='/topic/show?id=cfd19846697' target=_blank style='color:#2F92EE;'>#随机试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98466, encryptionId=cfd19846697, topicName=随机试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c3710444656, createdName=124985dbm09(暂无昵称), createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544657, encodeId=b80e154465e1b, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri Aug 14 02:17:44 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038947, encodeId=19a3103894e60, content=高质量研究,读起来真爽,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Wed Aug 12 14:17:44 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 肿瘤克星

    高质量研究,读起来真爽,谢谢梅斯

    0

相关资讯

那些年我们一起看过的瞳孔

经常遇到不少病人以意识不清来院就诊,体检发现针尖样瞳孔,这时候作为首诊医生的你能想到些什么?Case 1. 从网吧送来的年轻女性,因“被发现在网吧神志不清 3 小时”入院,由家人送至我院(送来之前已报警),查体浅昏迷,双侧瞳孔针尖样改变,家属无法提供详细病史,仅描述最近因家庭琐事情绪低落经常有轻生念想,急诊头颅 CT 未见异常,查胆碱酯酶 588 U/L。首先考虑有机磷农药中毒,予以解毒、护肝等对

Int Ophthalmol:跨瞳孔缝合对人工晶状体光学质量的影响

跨瞳孔缝合技术有时可用来固定人工晶状体(IOL),我们就10-0聚丙烯缝线用于跨瞳孔缝合时的光学效应进行研究。

PNAS:看瞳孔读懂别人的心思?

想读懂别人的心思?看看他们的瞳孔。根据一项刊登在PNAS上的最新研究,如果一个人对问题给出肯定回答(尤其是通常情况下他更倾向于用否定句回答问题),相较于给出否定回答的测试者,其瞳孔会更大。 一般而言,当人处于黑暗环境中时,为了使眼睛接收到更多光线以获得更佳视野,其瞳孔会放大。但当大脑自然分泌的化学物质的水平发生变化时,瞳孔的大小也会发生相应改变。。 在这项研究中,29&nb

Curr Eye Res:Ripasudil盐酸盐水合物滴眼对瞳孔动力学的影响

该研究的目的是为了探讨Ripasudil盐酸盐水合物(GLANATEC(R))滴眼后对瞳孔动力学的影响。14名健康受试者(除屈光不正外无其他眼科疾病)参加了该项研究,他们的平均年龄为30岁。采用单剂量的GLANATEC(R)滴注受试者左眼,测量滴注前与滴注后30分钟、120分钟的瞳孔反应,并同时检测眼内压。

PLOS ONE:眼睛会说话确有其事

俗话说,“眼睛是心灵的窗户”,“眼睛会说话”。日本一项新研究发现,人类和黑猩猩会因“同伴”的瞳孔放大或缩小而改变自己瞳孔的大小,从而证实眼睛在交际过程中确实发挥重要作用。 人类在交际时会根据各种因素不断调整自己的动作,比如对方点头时自己也会点头,在无意识情况下就会与对方动作保持同步。此前有研究显示,有的人在相互交流时,其眨眼也会保持同步,这种同步行动被认为是人类保持顺畅社交的基础。 人类和